Motivational interviewing for modifying diabetes risk: A randomised controlled trial

British Journal of General Practice

Volumn 58, Issue 553, 2008, Pages 535-540

  Greaves, Colin J ^a   Middlebrooke, Andrew ^b   O'Loughlin, Lucy ^c   Holland, Sandra ^c   Piper, Jane ^d   Steele, Anna ^d   Gale, Tracy ^d   Hammerton, Fenella ^c   Daly, Mark ^d  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c Devon Primary Care Trust   (United Kingdom)

^d ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Behaviour therapy; Diabetes mellitus; Intervention studies; Primary prevertion; Randomised controlled trial; Weight loss

Indexed keywords

ADULT; ARTICLE; BEHAVIOR MODIFICATION; BODY MASS; CLINICAL TRIAL; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE DELIVERY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; SINGLE BLIND PROCEDURE; UNITED KINGDOM; WEIGHT REDUCTION;

ATTITUDE TO HEALTH; COUNSELING; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HEALTH PROMOTION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MOTIVATION; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 49149131542     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp08X319648     Document Type: Article

References (31)

1. Knowler WC, Barrett-Connor E, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Eng J Med 2002; 346(6): 393-403.
2. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4): 537-544.
3. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 2001; 344(18): 1343-1350.
4. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368(9548): 1673-1679.
5. Gabir M, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000; 23(8): 1108-1112.
6. Heneghan C, Thompson M, Perera R. Prevention of diabetes. BMJ 2006; 333(7572): 764-765.
7. Goldberg RB. Lifestyle interventions to prevent type 2 diabetes. Lancet 2006; 368(9548): 1634-1936.
8. Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd edn. New York, NY: Guildford Press, 2002.
9. Knight KM, McGowan L, Dickens C, Bundy C. A systematic review of motivational interviewing in physical health care settings. Br J Health Psychol 2006; 11 (Pt 2): 319-332.
10. Miller WR. Motivational interviewing in service to health promotion. Am J Health Promot 2004; 18(3): A1-A10.
11. Vanwormer JJ, Boucher JL. Motivational interviewing and diet modification: a review of the evidence. Diabetes Educ 2004; 30(3): 404-419.
12. Motivational interviewing: MINT trainers. Motivational Interviewing Network of Trainers. http://motivationalinterview.org/training/ trainers.html (accessed 29 Apr 2008).
13. Bundy C. Changing bebaviour: using motivational interviewing techniques. J R Soc Med 2004; 97 Suppl 44: 43-47.
14. Lane C, Huws-Thomas M, Hood K, et al. Measuring adaptations of motivational interviewing: the development and validation of the Behavior Change Counseling Index (BECCI). Patient Educ Couns 2005; 56(2): 166-173.
15. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003; 71(5): 843-861.
16. Rubak S, Sandboek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005; 55(513): 305-312.
17. American Diabetes Association. Screening for diabetes. Diabetes Care 2004; 27 (Suppl 1): S11-S14.
18. Department of Health. Choosing health: making healthier choices easier. London: Department of Health, 2004.
19. Wang J. Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor's office. Am J Clin Nutr 2003; 78(5): 902-903.
20. Kriska AM, Caspersen CJ. Introduction to the collection of physical activity questionnaires. Med Sci Sports Exerc 1997; 29: S73-S78.
21. Roland M, Torgerson DJ. Understanding controlled trials: what are pragmatic trials? BMJ 1998; 316(7165): 285.
22. Shephard RJ. Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 2003; 37(3): 197-206.
23. Renders CM, Renders CM, Valk GD, et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001; CD001481.
24. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8(21): iii-iv, 1-182.
25. Pryke R, Docherty A. Obesity in primary care: evidence for advising weight constancy rather than weight loss in unsuccessful dieters. Br J Gen Pract 2008; 58(547): 112-117.
26. Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns 2008; 70(1): 31-39.
27. Evans PH, Greaves CJ, Winder R, et al. Development of an educational 'toolkit' for health professionals and their patients with prediabetes: the WAKEUP study (Ways of Addressing Knowledge Education and Understanding in Pre-diabetes). Diabet Med 2006; 24(7): 770-777.
28. Lindgren P, Lindström J, Tuomilehto J, et al. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective. Int J Technol Assess Health Care 2007; 23(2): 177-183.
29. The Diabetes Prevention Programme Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003; 26(9): 2518-2523.
30. Foxcroft DR, Milne R. Orlistat for the treatment of obesity: rapid review and cost-effectiveness model. Obes Rev 2000; 1(2): 121-126.
31. Michie S, Abraham C. Interventions to change health behaviours: evidence-based or evidence-inspired. Psychol Health 2004; 19(1): 29-50.